Analysis

The biopharmaceutical company aTyr Pharma is entering a pivotal period for its lead therapeutic candidate, efzofitimod. Two major clinical and...

Investors in Santacruz Silver Mining witnessed a historic rally during 2025. The current picture, however, is dominated by a pronounced...

Market participants are closely monitoring the upcoming US planting intentions report, as the global soybean landscape presents a mixed picture....

Integrated energy giant Suncor Energy is experiencing significant tailwinds in equity markets, propelled by robust operational performance and a dependable...

The spring of 2026 is shaping up to be a pivotal period for U.S. tobacco giant Altria. As the company...

As spring approaches, Axsome Therapeutics finds itself at a critical juncture. The biopharmaceutical firm is strengthening its commercial footing with...

While D-Wave Quantum Inc. showcases significant technological progress and secures key contracts, its equity valuation tells a story of persistent...

The German biotech firm BioNTech is navigating its most significant transition since the peak of the pandemic. Co-founders Ugur Sahin...

Palantir Technologies continues to deepen its footprint within the defense sector, a strategic move highlighted by its expanded alliance with...

Uranium Energy Corp. presented its second-quarter fiscal 2026 results on March 10, revealing a mixed financial picture. The company benefits...